CBAV — Clinica Baviera SA Cashflow Statement
0.000.00%
Last trade - 00:00- €469.21m
- €421.77m
- €224.92m
- 99
- 48
- 91
- 94
Annual cashflow statement for Clinica Baviera SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 17.8 | 20.2 | 38.9 | 40.7 | 49.7 |
| Depreciation | |||||
| Non-Cash Items | 0.576 | -0.317 | 1.31 | 2.36 | 1.07 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.19 | -1.96 | -7.44 | -4.66 | -9.89 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 25.4 | 31.5 | 46.9 | 53.4 | 57.8 |
| Capital Expenditures | -9.19 | -7.82 | -10.6 | -14 | -22.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.51 | -13.6 | -6.51 | 1.47 | -21.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.68 | -21.4 | -17.1 | -12.6 | -44.3 |
| Financing Cash Flow Items | -0.213 | -0.269 | -0.113 | -0.551 | -0.106 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -18.7 | -3.15 | -30.8 | -31.4 | -24.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.01 | 6.9 | -1.02 | 9.37 | -10.9 |